The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Regulation of the Proinflammatory Effects of Fas Ligand (CD95L)
Abstract
Fas ligand (CD95L) inhibits T cell function in immune-privileged organs such as the eye and testis, yet in most tissues CD95L expression induces potent inflammatory responses. With a stably transfected colon carcinoma cell line, CT26-CD95L, the molecular basis for these divergent responses was defined. When injected subcutaneously, rejection of CT26-CD95L was caused by neutrophils activated by CD95L. CT26-CD95L survived in the intraocular space because of the presence of transforming growth factor–β (TGF-β), which inhibited neutrophil activation. Providing TGF-β to subcutaneous sites protected against tumor rejection. Thus, these cytokines together generate a microenvironment that promotes immunologic tolerance, which may aid in the amelioration of allograft rejection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nagata, S., & Golstein, P. (1995) · Science · doi:10.1126/science.7533326 · Cited by 3,979
The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S.-I., Sameshima, M., Hase, A., Seto, Y., & Nagata, S. (1991) · Cell · doi:10.1016/0092-8674(91)90614-5 · Cited by 2,737
Raingeaud, J., Gupta, S., Rogers, J. S., Dickens, M., Han, J., Ulevitch, R. J., & Davis, R. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7420 · Cited by 2,241
Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege
Griffith, T. S., Brunner, T., Fletcher, S. M., Green, D. R., & Ferguson, T. A. (1995) · Science · doi:10.1126/science.270.5239.1189 · Cited by 2,005
Brunner, T., Mogil, R. J., LaFace, D., Yoo, N. J., Mahboubi, A., Echeverri, F., Martin, S. J., Force, W. R., Lynch, D. H., Ware, C. F., et al. (1995) · Nature · doi:10.1038/373441a0 · Cited by 1,314
Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape
Hahne, M., Rimoldi, D., Schröter, M., Romero, P., Schreier, M., French, L. E., Schneider, P., Bornand, T., Fontana, A., Lienard, D., et al. (1996) · Science · doi:10.1126/science.274.5291.1363 · Cited by 1,249
A role for CD95 ligand in preventing graft rejection
Bellgrau, D., Gold, D., Selawry, H., Moore, J., Franzusoff, A., & Duke, R. C. (1995) · Nature · doi:10.1038/377630a0 · Cited by 1,155
Strand, S., Hofmann, W. J., Hug, H., Müller, M., Otto, G., Strand, D., Mariani, S. M., Stremmel, W., Krammer, P. H., & Galle, P. R. (1996) · Nature Medicine · doi:10.1038/nm1296-1361 · Cited by 897
The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand.
O'Connell, J., O'Sullivan, G. C., Collins, J. K., & Shanahan, F. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.3.1075 · Cited by 878
Episomal Vectors Rapidly and Stably Produce High-Titer Recombinant Retrovirus
Kinsella, T. M., & Nolan, G. P. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.12-1405 · Cited by 734
The Role of Fas in Autoimmune Diabetes
Chervonsky, A. V., Wang, Y., Wong, F. S., Visintin, I., Flavell, R. A., Janeway, C. A., & Matis, L. A. (1997) · Cell · doi:10.1016/s0092-8674(00)80178-6 · Cited by 496
Kang, S.-M., Schneider, D. B., Lin, Z., Hanahan, D., Dichek, D. A., Stock, P. G., & Baekkeskov, S. (1997) · Nature Medicine · doi:10.1038/nm0797-738 · Cited by 450
Prevention of Islet Allograft Rejection with Engineered Myoblasts Expressing FasL in Mice
Lau, H. T., Yu, M., Fontana, A., & Stoeckert, C. J. (1996) · Science · doi:10.1126/science.273.5271.109 · Cited by 445
CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival.
Stuart, P. M., Griffith, T. S., Usui, N., Pepose, J., Yu, X., & Ferguson, T. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119173 · Cited by 367
Allison, J., Georgiou, H. M., Strasser, A., & Vaux, D. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.3943 · Cited by 366
Zu, Y., Qi, J., Gilchrist, A., Fernandez, G. A., Vázquez‐Abad, D., Kreutzer, D. L., Huang, C. K., & Sha'afi, R. I. (1998) · PubMed · Cited by 330
Antitumor effect of locally produced CD95 ligand
Seino, K.-I., Kayagaki, N., Okumura, K., & Yagita, H. (1997) · Nature Medicine · doi:10.1038/nm0297-165 · Cited by 312
Nick, J. A., Avdi, N. J., Young, S. K., Knall, C., Gerwins, P., Johnson, G. L., & Worthen, G. S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119263 · Cited by 300
Zu, Y.-L., Qi, J., Gilchrist, A., Fernandez, G. A., Vazquez-Abad, D., Kreutzer, D. L., Huang, C.-K., & Sha’afi, R. I. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.4.1982 · Cited by 283
Distinct Cellular Interactions of Secreted and Transmembrane Ebola Virus Glycoproteins
Yang, Z.-Y., Delgado, R., Xu, L., Todd, R. F., Nabel, E. G., Sanchez, A., & Nabel, G. J. (1998) · Science · doi:10.1126/science.279.5353.1034 · Cited by 261
Self-citationGene transfer of Fas ligand induces tumor regression in vivo
Arai, H., Gordon, D., Nabel, E. G., & Nabel, G. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13862 · Cited by 248
Self-citationEndothelial cell killing by neutrophils. Synergistic interaction of oxygen products and proteases.
Varani, J., Ginsburg, I., Schuger, L. A., Gibbs, D. F., Bromberg, J., Johnson, K. J., Ryan, U. S., & Ward, P. A. (1989) · Europe PMC (PubMed Central) · Cited by 194
Okrent, D. G., Lichtenstein, A. K., & Ganz, T. (1990) · American Review of Respiratory Disease · doi:10.1164/ajrccm/141.1.179 · Cited by 158
Arrick, B. A., Lopez, A. R., Elfman, F., Ebner, R., Damsky, C. H., & Derynck, R. (1992) · The Journal of Cell Biology · doi:10.1083/jcb.118.3.715 · Cited by 154
Fas-ligand: Privilege and peril
Green, D. R., & Ware, C. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.5986 · Cited by 142
Nahas, N., Molski, T. F. P., FERNANDEZ, G. A., & Sha'afi, R. I. (1996) · Biochemical Journal · doi:10.1042/bj3180247 · Cited by 128
Inhibition of the alloantibody response by CD95 ligand
Arai, H., Chanz, S. Y., Bishop, D. K., & Nabel, G. J. (1997) · Nature Medicine · doi:10.1038/nm0897-843 · Cited by 81
Self-citationImmune Response and Myoblasts That Express Fas Ligand
Kang, S., Hofmann, A., Le, D., Springer, M. L., Stock, P. G., & Blau, H. M. (1997) · Science · doi:10.1126/science.278.5341.1322 · Cited by 78
Muhaya, M., Calder, V. L., Towler, H. M. A., Shaer, B., Mclauchlan, M., & Lightman, S. (1998) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1998.00428.x · Cited by 78
Tumor Secretion of Growth Factors
Daughaday, W. H., & Deuel, T. F. (1991) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30258-5 · Cited by 75
Pazdrak, K., Justement, L. B., & Alam, R. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.9.4454 · Cited by 68
Eye-derived cytokines and the immunosuppressive intraocular microenvironment: a review
Streilein, J. W., Wilbanks, G. A., Taylor, A. W., & Cousins, S. W. (1992) · Current Eye Research · doi:10.3109/02713689208999510 · Cited by 59
Liles, W. C., Ledbetter, J. A., Waltersdorph, A. W., & Klebanoff, S. J. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.4.2175 · Cited by 47
Berrou, E., Fontenay, M., Quarck, R. A., McKenzie, F. R., Levy-Toledano, S., Tobelem, G., & Bryckaert, M. (1996) · Biochemical Journal · doi:10.1042/bj3160167 · Cited by 24
Cited by
TGF-β Signaling in Tumor Suppression and Cancer Progression
Derynck, R., Akhurst, R. J., & Balmain, A. (2001) · Nature Genetics · doi:10.1038/ng1001-117 · Cited by 2,275
“Indeed, Fas ligand–expressing carcinoma cells underwent neutrophil-mediated rejection, but this rejection did not occur at a site with high levels of TGF-β or when TGF-β1 was injected at the tumor sit”
BackgroundImmunosuppressive Strategies that are Mediated by Tumor Cells
Rabinovich, G. A., Gabrilovich, D., & Sotomayor, E. M. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141609 · Cited by 1,702
Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer
Siegel, P. M., & Massagué, J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1208 · Cited by 1,604
Phan, G. Q., Yang, J. C., Sherry, R. M., Hwu, P., Topalian, S. L., Schwartzentruber, D. J., Restifo, N. P., Haworth, L. R., Seipp, C. A., Freezer, L. J., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1533209100 · Cited by 1,575
TGFβ: the molecular Jekyll and Hyde of cancer
Bierie, B., & Moses, H. L. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1926 · Cited by 1,267
Metadata
- Authors
- Chen, J.-J., Sun, Y., & Nabel, G. J.
- Venue
- Science
- Published
- 1998-11-27
- Volume
- 282
- Issue
- 5394
- Pages
- 1714-1717
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1993199753
- Cited by
- 383
- References
- 34
- FWCI
- 11.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.